Impact of a CART promoter genetic variation on plasma lipid profile in a general population

Molecular Genetics and Metabolism

Volumn 90, Issue 2, 2007, Pages 199-204

  Vasseur, Francis ^a,b   Guérardel, Audrey ^a   Barat Houari, Mouna ^a   Cottel, Dominique ^a   Amouyel, Philippe ^a,b   Froguel, Philippe ^a,c   Helbecque, Nicole ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atherogenic (hypercholesterolemia) protection; CART; Polymorphism

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CHOLESTEROL; FEMALE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 33846370514     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.08.012     Document Type: Article

References (31)

1. Hunter R.G., and Kuhar M.J. CART peptides as targets for CNS drug development. Curr. Drug Target CNS Neurol. Disord. 2 (2003) 201-205
2. Vrang N., Tang-Christensen M., Larsen P.J., and Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res. 818 (1999) 499-509
3. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
4. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., and Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29 (1998) 293-298
5. Wang C., Billington C.J., Levine A.S., and Kotz C.M. Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. Neuroreport 11 (2000) 3251-3255
6. Rohner-Jeanrenaud F., Craft L.S., Bridwell J., Suter T.M., Tinsley F.C., Smiley D.L., Burkhart D.R., Statnick M.A., Heiman M.L., Ravussin E., and Caro J.F. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats. Int. J. Obes. Relat Metab. Disord. 26 (2002) 143-149
7. Asnicar M.A., Smith D.P., Yang D.D., Heiman M.L., Fox N., Chen Y.F., Hsiung H.M., and Koster A. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142 (2001) 4394-4400
8. Moffett M., Stanek L., Harley J., Rogge G., Asnicar M., Hsiung H., and Kuhar M. Studies of cocaine- and amphetamine-regulated transcript (CART) knockout mice. Peptides 27 (2006) 2037-2045
9. Wierup N., Richards W.G., Bannon A.W., Kuhar M.J., Ahren B., and Sundler F. CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul. Pept. 129 (2005) 203-211
10. Abbott C.R., Rossi M., Wren A.M., Murphy K.G., Kennedy A.R., Stanley S.A., Zollner A.N., Morgan D.G., Morgan I., Ghatei M.A., Small C.J., and Bloom S.R. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 142 (2001) 3457-3463
11. Vicentic A., and Jones D.C. The CART system in appetite and drug addiction. J. Pharmacol. Exp. Ther. (2006)
12. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., Rissanen A., Dekker J.M., 't Hart L.M., Valve, and Uusitupa M.I. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4 (1998) 1434-1437
13. Sudo Y., Ezura Y., Kajita M., Yoshida H., Suzuki T., Hosoi T., Inoue S., Shiraki M., Ito H., and Emi M. Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women. J. Hum. Genet. 50 (2005) 235-240
14. Hager J., Dina C., Francke S., Dubois S., Houari M., Vatin V., Vaillant E., Lorentz N., Basdevant A., Clement K., Guy-Grand B., and Froguel P. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat. Genet. 20 (1998) 304-308
15. Guerardel A., Barat-Houari M., Vasseur F., Dina C., Vatin V., Clement K., Eberle D., Vasseur-Delannoy V., Bell C.G., Galan P., Hercberg S., Helbecque N., Potoczna N., Horber F.F., Boutin P., and Froguel P. Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet. 6 (2005) 19
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. Tregouet D.A., Barbaux S., Escolano S., Tahri N., Golmard J.L., Tiret L., and Cambien F. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet. 11 (2002) 2015-2023
18. Ceddia R.B., Koistinen H.A., Zierath J.R., and Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 16 (2002) 1163-1176
19. Kinosian B., Glick H., Preiss L., and Puder K.L. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J. Investig. Med. 43 (1995) 443-450
20. Fu M., Cheng H., Chen L., Wu B., Cai M., Xie D., and Fu Z. [Association of the cocaine and amphetamine-regulated transcript gene with type 2 diabetes mellitus]. Zhonghua Nei Ke Za Zhi 41 (2002) 805-808
21. Challis B.G., Yeo G.S., Farooqi I.S., Luan J., Aminian S., Halsall D.J., Keogh J.M., Wareham N.J., and O'Rahilly S. The CART gene and human obesity: mutational analysis and population genetics. Diabetes 49 (2000) 872-875
22. del Giudice E.M., Santoro N., Cirillo G., D'Urso L., Di Toro R., and Perrone L. Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50 (2001) 2157-2160
23. Cota D., Marsicano G., Tschop M., Grubler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thone-Reineke C., Ortmann S., Tomassoni F., Cervino C., Nisoli E., Linthorst A.C., Pasquali R., Lutz B., Stalla G.K., and Pagotto U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112 (2003) 423-431
24. Osei-Hyiaman D., Depetrillo M., Harvey-White J., Bannon A.W., Cravatt B.F., Kuhar M.J., Mackie K., Palkovits M., and Kunos G. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 81 (2005) 273-282
25. Schrauwen P., Xia J., Walder K., Snitker S., and Ravussin E. A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 mRNA expression and obesity in male non-diabetic Pima Indians. Int. J. Obes Relat. Metab. Disord. 23 (1999) 1242-1245
26. Meirhaeghe A., Amouyel P., Helbecque N., Cottel D., Otabe S., Froguel P., and Vasseur F. An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 43 (2000) 1424-1428
27. Bahceci M., Tuzcu A., Akkus M., Yaldiz M., and Ozbay A. The effect of high-fat diet on the development of obesity and serum leptin level in rats. Eat. Weight Disord. 4 (1999) 128-132
28. Wortley K.E., Chang G.Q., Davydova Z., Fried S.K., and Leibowitz S.F. Cocaine- and amphetamine-regulated transcript in the arcuate nucleus stimulates lipid metabolism to control body fat accrual on a high-fat diet. Regul. Pept. 117 (2004) 89-99
29. Wu D.M., Shen M.H., and Chu N.F. Relationship between plasma leptin levels and lipid profiles among school children in Taiwan-the Taipei Children Heart Study. Eur. J Epidemiol. 17 (2001) 911-916
30. Vanpatten S., Karkanias G.B., Rossetti L., and Cohen D.E. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem. J. 379 (2004) 229-233
31. Wierup N., Bjorkqvist M., Kuhar M.J., Mulder H., and Sundler F. CART Regulates Islet Hormone Secretion and is expressed in the β-Cells of Type 2 Diabetic Rats. Diabetes 55 (2006) 305-311